Literature DB >> 10926796

Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.

A S Wong1, P C Leung, N Auersperg.   

Abstract

OBJECTIVE: Hepatocyte growth factor (HGF) enhances cell dissociation and morphogenesis in many forms of carcinomas including some, but not all, cervical carcinomas. In this study, we examined the effects of HGF on two cervical cancer cell lines, derived from the same tumor, with different growth patterns in vivo and in vitro.
METHODS: Two cell lines, derived from the same cervical carcinoma, express spinous (C-4I) and basal (C4-II) squamous cell differentiation, respectively. A cell scattering assay was used to determine whether HGF would stimulate cell dissociation and motility. The morphogenetic capacity of HGF was assessed in collagen gel cultures, expression of the HGF receptor c-Met by Western blot analysis, and cadherin expression by immunofluorescence microscopy.
RESULTS: HGF-induced cell scattering was intense in C-4II, but limited in C-4I cultures. In collagen gels, C-4I cells formed large, spherical compact colonies with necrotic centers while C-4II cells formed small, irregular colonies with no necrosis. HGF induced proliferation and branching morphogenesis in both lines, but more prominently in C-4II cultures. There was no difference in c-Met or E- and P-cadherin expression between C-4I and C-4II cultures, but the lines differed in their signal transduction responses to HGF. The scatter response was mediated primarily by phosphatidylinositol 3-kinase in line C-4I, but by mitogen-activated protein kinase in line C-4II. HGF induced collagen gel contraction by C-4 cells, demonstrating for the first time that HGF has the capacity to induce this function.
CONCLUSIONS: The HGF-induced cell dispersion, morphogenesis, and collagen gel contraction in two cervical carcinoma cell lines were greatly influenced by differences between the lines in differentiation-associated properties. These properties, which include variations in extracellular matrix, junctional proteins, and signal transduction, may also modulate HGF action in vivo and thus determine patterns of invasiveness and growth of cervical carcinomas. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926796     DOI: 10.1006/gyno.2000.5877

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Three-Dimensional Spatiotemporal Modeling of Colon Cancer Organoids Reveals that Multimodal Control of Stem Cell Self-Renewal is a Critical Determinant of Size and Shape in Early Stages of Tumor Growth.

Authors:  Huaming Yan; Anna Konstorum; John S Lowengrub
Journal:  Bull Math Biol       Date:  2017-07-05       Impact factor: 1.758

3.  c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.

Authors:  Tamer Refaat; Eric D Donnelly; Sean Sachdev; Vamsi Parimi; Samar El Achy; Prarthana Dalal; Mohamed Farouk; Natasha Berg; Irene Helenowski; Jeffrey P Gross; John Lurain; Jonathan B Strauss; Gayle Woloschak; Jian-Jun Wei; William Small
Journal:  Am J Clin Oncol       Date:  2017-12       Impact factor: 2.339

4.  A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Authors:  Lainie P Martin; Michael Sill; Mark S Shahin; Matthew Powell; Paul DiSilvestro; Lisa M Landrum; Stephanie L Gaillard; Michael J Goodheart; James Hoffman; Russell J Schilder
Journal:  Gynecol Oncol       Date:  2013-12-18       Impact factor: 5.482

5.  Aqueous two-phase printing of cell-containing contractile collagen microgels.

Authors:  Christopher Moraes; Arlyne B Simon; Andrew J Putnam; Shuichi Takayama
Journal:  Biomaterials       Date:  2013-09-10       Impact factor: 12.479

6.  MET receptor is a potential therapeutic target in high grade cervical cancer.

Authors:  Katarzyna Miekus; Marta Pawlowska; Małgorzata Sekuła; Grazyna Drabik; Zbigniew Madeja; Dariusz Adamek; Marcin Majka
Journal:  Oncotarget       Date:  2015-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.